It also targets other cells in the pancreas to stop the glucagon signal for generating glucose in the liver.[ref] In clinical trials, GLP-1 RAs improved lipid profiles, increased satiety, slowed gastric emptying, reduced inflammation, and had neuroprotective effects.[ref] The slowing of gastric emptying and reducing inflammation may play a role in weight loss, along with the decrease in appetite and eating less
Moreover, scholarly articles report that HIF-2 activation in colorectal cancer notably increases gene expression relating to lipid and iron metabolism, promoting the cell prone to ferroptosis [8]
This is well recognized in people that [train] animals for operant responding for drugs, Rinaman said
Zepbound (tirzepatide) injection prescribing information
As policymakers debate coverage, clinicians weigh long-term strategies, and society argues over who deserves access, the voices in this study are a reminder that the story of GLP-1 medications was never only about weight loss as much as it is about agency